British Pharmaceutical Conference (BPC) 2007

Home > British Pharmaceutical Conference > News and reports

British Pharmaceutical Conference 2007 www.bpc2007.org  Manchester International Convention Centre (10-12 September)

BPC reports supplement (PDF 1.3 MB)

Reports (pages): 294   295   296-297   298   303   304   305   PDF (380K) |  News (PDF 60K)

294 National templates will support role for pharmacy in influenza immunisation Coverage of this year's British Pharmaceutical Conference starts with a report of health minister Ben Bradshaw's address from Tom Moberly, who also covers the speech by Hemant Patel, President of the Royal Pharmaceutical Society
PJ 2007;279:294
Full Text   PDF (40K)


295 Members will determine details of the new professional body for pharmacy Tom Moberly reports on developments in professional leadership
PJ 2007;279:295
Full Text   PDF (50K)


296-297 Conference on camera
PJ 2007;279:296-297
PDF (230K)


298 Control and supervision now separated Harriet Adcock, Hannah Pike, Gemma Cleveland and Olivia Timbs reports include control and supervision
PJ 2007;279:298
Full Text   PDF (40K)


303 Science jobs seen as low-paid and dull Harriet Adcock, Hannah Pike, Gemma Cleveland and Olivia Timbs reports include science and careers forum
PJ 2007;279:303
Full Text   PDF (60K)


304 Highlights from the 2007 conference practice research sessions This year's British Pharmaceutical Conference saw the presentation of 85 practice research papers. An extensive review will be published in the BPC supplement but in this article, Clare Bellingham picks out some highlights
PJ 2007;279:304
Full Text   PDF (30K)


305 A taster of science research advances Joseph Chamberlain provides a selection of highlights of the science presentations. A more extensive review will appear in the BPC supplement
PJ 2007;279:305
Full Text   PDF (30K)


BPC reports supplement

Leading article   Plenary   Science   Practice


BPC past and future   Conference on camera  |  Supplement (PDF 1.3 MB)

Leading article

B2 The medicines maze
PJ 2007;279:(suppl) B2
PDF (30K)

Plenary session

B5 Real risks and perceived risks in focus Speakers at the first plenary session of the conference looked at different aspects of risk
Olivia Timbs reports

PJ 2007;279:(suppl) B5
PDF (40K)

Science chairman

B3-4 Science chairman’s address: joining up the risk versus benefit argument Modern pharmacists need to be able to manage risk and benefit, Clive Wilson says
PJ 2007;279:(suppl) B3-4
PDF (80K)


Science sessions

B8 From philosophy to patient benefit Speakers at a session entitled “Drug evaluation in the 21st century” looked at the successes of drug development
Olivia Timbs and Ann Lewis report

PJ 2007;279:(suppl) B8
PDF (30K)

B14 Talk to patients in their own language Communicating risk and benefit to patients was the theme of a session chaired by Joanne Rule, of Cancerbackup
Harriet Adcock reports

PJ 2007;279:(suppl) B14
PDF (40K)

B15 Patient reporting of adverse events Patient perception of medicines regulation and the need to encourage them to send in reports of adverse events were discussed at a session led by the Medicines and Healthcare Products Regulatory Agency
Hannah Pike reports

PJ 2007;279:(suppl) B15
PDF (40K)

B16 Involve patients in clinical trial design Economic evaluation and the NICE appraisal process were discussed during a session chaired by broadcaster Peter White
Harriet Adcock reports

PJ 2007;279:(suppl) B16
PDF (30K)

B17 OTC formulations unlikely to be of use in preventing progression of mild AMD Participants at a session on the emerging pattern of blindness in the West heard about developments in prevention, care and cures
Tom Moberly reports

PJ 2007;279:(suppl) B17
PDF (30K)

B18 Detox — is it really good for you? / Risk mitigation in formulation development One presentation revealed the truth about popular “detox” regimens and products, and another gave suggestions on risk mitigation in formulation development
Gemma Cleveland reports on two science of pharmacy sessions

PJ 2007;279:(suppl) B18
PDF (30K)


Science abstracts
B9-13 BPC science abstracts review This year 170 science abstracts were presented at the British Pharmaceutical Conference
Joseph Chamberlain reviews a selection

PJ 2007;279:(suppl) B9-13
PDF (180K)

BPC past and future

Treasures of the Royal Pharmaceutical Society's Collections
B22 Society treasues: a little bit of history Briony Hudson, keeper of the Royal Pharmaceutical Society museum collections, describes a collection of badges from past British Pharmaceutical Conferences
PJ 2007;279:(suppl) B22
PDF (70K)

BPC 2008
B22 BPC 2008: “Adding years to life and life to years”
PJ 2007;279:(suppl) B22
PDF (70K)

Practice chairman

B19-21 Practice chairman’s address: To be or not to be taken? That is the question Theo Raynor discusses research into information on patient leaflets and medicines labels and calls for this to be improved and better used
PJ 2007;279:(suppl) B19-21
PDF (50K)

Practice sessions

B23 Patient priorities need to be considered Participants at a session on communicating risks and benefits to people with special needs heard that understanding patients is key
Tom Moberly reports

PJ 2007;279:(suppl) B23
PDF (40K)

B26-27 Progress achieved with new pharmacy contract but room for improvement A major evaluation of the community pharmacy contract in England and Wales was presented at BPC
Harriet Adcock and Tom Moberly report

PJ 2007;279:(suppl) B26-27
PDF (50K)

B28-29 The brave new world of pharmacy? Four models of pharmacy services were put to a panel of experts in a Dragons' Den style symposium
Harriet Adcock reports

PJ 2007;279:(suppl) B28-29
PDF (60K)

B30 Statin therapy — should we put public health before individual choice? The benefits and complications of statin therapy for the primary prevention of cardiovascular disease (CVD) were discussed in a practice session
Hannah Pike reports

PJ 2007;279:(suppl) B30
PDF (40K)

B31 Safety issues with OTC medicines / A dose of specially formulated information Gemma Cleveland reports on two sessions on safety issues associated with OTC medicines and on the NHS's new information prescription service
PJ 2007;279:(suppl) B31
PDF (40K)

B32 Issues regarding the safety of herbals Herbal products may have medicinal effects but the industry is largely unregulated
Gemma Cleveland reports on what is being done to address this

PJ 2007;279:(suppl) B32
PDF (40K)

B33 Special interests: update on progress Beth Taylor, national development lead for pharmacists with special interests at NHS Primary Care Contracting, reports on the session on these pharmacists. Mrs Taylor also spoke at the session, giving an overview of the initiative
PJ 2007;279:(suppl) B33
PDF (30K)

B34 Pharmacy in a secure environment — progress and problems in prisons The health of people in prisons, problems with their medicines, and progress with schemes such as “in-possession medication” were discussed at a session on prison pharmacy.
Davan Eustace reports

PJ 2007;279:(suppl) B34
PDF (50K)

B35 Self-administration — what are the benefits and where is the evidence? Participants heard about self-administration from pharmacists working in mental health and paediatrics, and also heard from a patient. They then had a lively debate about whether self-administration should be an indicator in the Healthcare Commission's health check
Hannah Pike reports

PJ 2007;279:(suppl) B35
PDF (40K)

B36 Informing children about medicines Challenges of keeping children and young people well informed about their medicines were discussed in a session entitled “What about the children?”
Hannah Pike reports

PJ 2007;279:(suppl) B36
PDF (40K)

B37-38 Introducing the idea of fair blame In a session about professional regulation, presenters spoke about the legal and practical implications of dispensing errors
Olivia Timbs reports

PJ 2007;279:(suppl) B37-38
PDF (50K)


Practice abstracts

B39-42 Pharmacy practice research: a review This year's British Pharmaceutical Conference included 85 pharmacy practice research papers
Clare Bellingham reviews a selection

PJ 2007;279:(suppl) B39-42
PDF (70K)

Conference on camera

B6-7, 24-25 Conference on camera
PJ 2007;279:(suppl) B6-7, 24-25
PDF (410K)

Back to Top


©The Pharmaceutical Journal